StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics

StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)

StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 3.9 % Shares of NYSE:BTX opened at $2.23 on Friday. The company’s 50 day moving average price is $3.04. The stock has a market […]

Related Keywords

Brooklyn Immunotherapeutics , Eterna Therapeutics Inc , Securities Exchange Commission , Advisors Group , Brooklyn Immunotherapeutics Inc , Get Rating , Street Advisors Group , Nyse Btx , Kbtx , Information , Initiated Coverage , Stocknews Com ,

© 2025 Vimarsana